CĂRȚI ÎN POLONEZĂ ÎN LEGĂTURĂ CU «KRUPADA»
Descoperă întrebuințarea
krupada în următoarea selecție bibliografică. Cărți în legătură cu
krupada și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Poloneză.
1
Human Growth Hormone: Research and Clinical Practice - Strona 65
Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, Thorner MO. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J Clin Endocrinol Metab 1994;79:943–949 ...
Roy G. Smith, Michael O. Thorner, 2000
2
Growth Hormone Secretagogues: Basic Findings and Clinical ...
Gertz, B.J., Barret, J.S., Eisenhaendler, R., Krupa, D.A., Wittreich, J.M., Seibold, J.R. and Schneider, S.H. (1993) Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. JCE&M 77 ...
E. Ghigo, M. Boghen, F.F. Casanueva, 1999
3
Insecticides with Novel Modes of Action: Mechanisms and ...
ACS Symp Ser no 255. American Chemical Society, Washington, DC, pp 5–20 Campos F, Dybas RA, Krupa DA (1995) Susceptibility of twospotted spider mite, Tetranychus urticae (Acari: Tetranychidae) populations in California to abamectin.
Isaac Ishaaya, Danny Degheele, 2013
4
Biorational Control of Arthropod Pests: Application and ... - Strona 386
J Econ Entomol 90: 1 125-1 130 Campos F, Dybas RD, Krupa DA (1995) Susceptibility of twospotted spider mite (Acari: Tetranychidae) populations in California to abamectin. J Econ Entomol 88: 225-231 Campos F, Krupa DA, Dubas RA ...
Isaac Ishaaya, A. Rami Horowitz, 2009
5
Growth Hormone in Adults: Physiological and Clinical Aspects
Endocrinology 135: 1100–1108 Hickey, G., Jacks, T., Schleim, K., Frazier, E., Chen, H.Y., Krupa, D.A., Feeny, W.P., Nargund, R.P., Patchett, A.A., Smith, R.G. (1997). Repeat administration of growth hormone secretagogue MK-0677 increases ...
Anders Juul, Jens O. L. Jorgensen, 2000
6
Insect Pharmacology: Channels, Receptors, Toxins and Enzymes
5–20. Campbell, W.C., Fisher, M.H., Stapley, E.O., AlbersSchonberg, T., Jacob, T.A., 1983. Ivermectin: a potent new antiparasitic agent. Science 221, 923–928. Campos, F.C., Dybas, R.A., Krupa, D.A., 1995. Susceptibility of twospotted spider ...
Lawrence I. Gilbert, Sarjeet S. Gill, 2010
7
Food for the Ageing Population - Strona 66
Drugs Aging 9, 221±5. CHAPMAN IM (2004): Endocrinology of anorexia of aging. Best Pract & Res 18 (3), 437± 52. CHAPMAN JM, BACH MA, VAN CAUTER E, FARMER M, KRUPA DA, TAYLOR AM, SCHILLING LM, COLE KY, SKYLES EH, ...
M M Raats, Lisette De Groot, Dieneke van Asselt, 2008
8
Rethinking Corporate Governance: From Shareholder Value to ...
... to the supervisory board constitutes a drawback (mankament) from the point of view of the owners of the company as it restricts the freedom of management. See also R. Krupa-Da ̨browska, Przedsie ̨biorcy nieche ̨tni spo ́łkom ...
Roger Blanpain, William Bromwich, Olga Rymkevich, 2011
9
From Acute to Chronic Back Pain: Risk Factors, Mechanisms, ...
Katz, N.P., Iu, W.D., Krupa, D.A., et al. (2003). Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4—week, randomized, placebo—controlled, parallel— group, double—blind trials. Spine, 28, 851-59. Keefe ...
Monika I. Hasenbring, Adina C. Rusu, Dennis C. Turk, 2012
10
Evidence-Based Management of Low Back Pain - Strona 153
Ju WD, Krupa DA, Walters DJ, et al. A placebo-controlled trial of rofecoxib in the treatment of chronic low back pain. Pain Med 2001;2:242-243. Pallay RM, Seger W, Adler JL, et al. Etoricoxib reduced pain and disability and improved quality of ...
Simon Dagenais, Scott Haldeman, 2011
